Autolus Therapeutics plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 24.22 M | $87.92 M | 35.39% | 9.10% |
| BLACKSTONE INC. | 11/14/2024 | 20.49 M | $74.36 M | 0.00% | 7.70% |
| SYNCONA PORTFOLIO LTD | 11/14/2024 | 18.55 M | $67.35 M | -13.08% | 6.97% |
| FMR LLC | 11/13/2024 | 17.77 M | $64.52 M | 44.56% | 6.68% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 15.27 M | $55.44 M | 0.00% | 5.74% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2024 | 12.35 M | $44.81 M | 0.00% | 4.64% |
| TFG ASSET MANAGEMENT GP LTD | 11/14/2024 | 8.00 M | $29.04 M | 0.00% | 3.01% |
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 6.87 M | $24.95 M | 9.95% | 2.58% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 4.62 M | $16.78 M | 0.00% | 1.74% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 4.50 M | $16.34 M | 4.65% | 1.69% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 4.43 M | $16.07 M | 100.00% | 1.66% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 3.84 M | $13.95 M | -12.97% | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 3.64 M | $13.21 M | 0.00% | 1.37% |
| LAURION CAPITAL MANAGEMENT LP | 11/14/2024 | 3.19 M | $11.58 M | -12.52% | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 2.95 M | $10.71 M | -7.81% | 1.11% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2024 | 2.86 M | $10.40 M | 16.83% | 1.08% |
| GREAT POINT PARTNERS LLC | 11/13/2024 | 2.81 M | $10.21 B | -18.30% | 1.06% |
| STEMPOINT CAPITAL LP | 11/13/2024 | 2.62 M | $9.50 M | -1.73% | 0.98% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 1.83 M | $6.64 M | -27.70% | 0.69% |
| MORGAN STANLEY | 11/14/2024 | 1.82 M | $6.60 M | -37.42% | 0.68% |
| PERPETUAL LTD | 10/09/2024 | 1.60 M | $5.81 M | -33.38% | 0.60% |
| JPMORGAN CHASE & CO | 12/26/2024 | 1.28 M | $4.66 M | 145.31% | 0.48% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 1.06 M | $3.86 M | -10.61% | 0.40% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 1.03 M | $3.75 M | 0.00% | 0.39% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 862,804 | $3.13 M | 6.12% | 0.32% |
| MARSHALL WACE, LLP | 11/14/2024 | 757,535 | $2.75 M | 0.00% | 0.28% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 732,282 | $2.66 M | -27.20% | 0.28% |
| ALPHABET INC. | 11/08/2024 | 698,262 | $2.53 M | 0.00% | 0.26% |
| STATE STREET CORP | 11/14/2024 | 606,544 | $2.20 M | 1.74% | 0.23% |
| HIGHVISTA STRATEGIES LLC | 11/14/2024 | 533,024 | $1.93 M | 2.74% | 0.20% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 486,667 | $1.77 M | 40.38% | 0.18% |
| HEALTHINVEST PARTNERS AB | 11/12/2024 | 442,423 | $1.61 M | 95.64% | 0.17% |
| EVERSEPT PARTNERS, LP | 11/14/2024 | 406,558 | $1.48 M | -33.45% | 0.15% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 385,873 | $1.40 M | 1.46% | 0.15% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 364,995 | $1.32 M | -54.49% | 0.14% |
| MAI CAPITAL MANAGEMENT | 11/07/2024 | 329,239 | $1.20 M | -1.43% | 0.12% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 318,000 | $1.15 M | 23.88% | 0.12% |
| CITADEL ADVISORS LLC | 11/14/2024 | 303,008 | $1.10 M | -42.37% | 0.11% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 298,086 | $1.08 M | 100.00% | 0.11% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 267,040 | $969,355 | 5.34% | 0.10% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 250,871 | $910,662 | -78.09% | 0.09% |
| VONTOBEL HOLDING LTD. | 10/16/2024 | 200,941 | $729,416 | -2.97% | 0.08% |
| 11/14/2024 | 195,000 | $707.85 M | 0.00% | 0.07% | |
| PRIVIUM FUND MANAGEMENT B.V. | 11/01/2024 | 185,639 | $673,870 | 15.56% | 0.07% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 176,000 | $638,880 | 0.00% | 0.07% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 164,921 | $598,663 | 0.14% | 0.06% |
| UBS GROUP AG | 11/14/2024 | 156,978 | $569,830 | 15.60% | 0.06% |
| CETERA INVESTMENT ADVISERS | 11/13/2024 | 132,000 | $479,160 | -1.86% | 0.05% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 121,035 | $439,357 | -18.54% | 0.05% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 98,406 | $357,214 | -52.47% | 0.04% |
Autolus Therapeutics plcinstitutional Ownership - FAQ's
During the previous two years, 123 institutional investors and hedge funds held shares of Autolus Therapeutics plc. The most heavily invested institutionals were:
WELLINGTON MANAGEMENT GROUP LLP: 24.22 M
Blackstone Inc.: 20.49 M
Syncona Portfolio Ltd: 18.55 M
FMR LLC: 17.77 M
Deep Track Capital, LP: 15.27 M
Avoro Capital Advisors LLC: 12.35 M
67.03% of Autolus Therapeutics plc stock is owned by institutional investors.
Institutional investors have bought a total of 189.13 M shares in the last 24 months. This purchase volume represents approximately $429.32 M in transactions.